Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.
Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–86 (London, England).
Sattar N, Ho FK, Gill JM, et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes Metab Syndr. 2020;14:1149–51 One of the first studies to suggest BMI to COVID-19 hospitalisation association may be stronger in younger people and also in non-white ethnicities.
Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O’Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021. https://doi.org/10.1016/S2213-8587(21)00089-9A more reecnt study to report a linear increase in COVID-19 risk with rising BMI beyond 23kg/m2. Generally well done but limited by BMI measurements in routine health care.
Hoong CWS, Hussain I, Aravamudan VM, Phyu EE, Lin JHX, Koh H. Obesity is associated with poor Covid-19 outcomes: a systematic review and meta-analysis. Horm Metab Res. 2021;53:85–93.
Chang T, Chou C-C, Chang L-Y. Effect of obesity and body mass index on coronavirus disease 2019 severity: a systematic review and meta-analysis. Obes Rev. 2020;21:e13089.
Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:823–33.
Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J. 2020;41:221–6 An excellent genetic study which shows elevated BMI is causally related to many cardiovascular outcomes.
Leong A, Cole JB, Brenner LN, Meigs JB, Florez JC, Mercader JM. Cardiometabolic risk factors for COVID-19 susceptibility and severity: a Mendelian randomization analysis. PLoS Med. 2021;18:e1003553 An excellent genetic study which shows elevated BMI is causally related to COVID-19 hospitalisation with the strength of the association beting at least twice as strong as suggested by observational data.
Aminian A, Fathalizadeh A, Tu C, Butsch WS, Pantalone KM, Griebeler ML, et al. Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity. Surg Obes Relat Dis. 2021;17:208–14.
Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020;142:4–6 A short synopsis of the multiple mechanisms that may explain the obesity to COVID-19 severity link.
Edwards DA, Ausiello D, Salzman J, et al. Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proc Natl Acad Sci U S A. 2021. https://doi.org/10.1073/pnas.2021830118Important study which shows people who are heavier exhale more COVID-19 in their breadth.
Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731.
Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314:52–60.
Braun ES, Crawford FW, Desai MM, et al. Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection. Infection. 2015;43:569–75.
Ni Y-N, Luo J, Yu H, Wang Y-W, Hu Y-H, Liu D, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21:36.
Deschasaux-Tanguy M, Druesne-Pecollo N, Esseddik Y, et al. Diet and physical activity during the coronavirus disease 2019 (COVID-19) lockdown (March–May 2020): results from the French NutriNet-Santé cohort study. Am J Clin Nutr. 2021;113:924–38.
Mulugeta W, Desalegn H, Solomon S. Impact of the COVID-19 pandemic lockdown on weight status and factors associated with weight gain among adults in Massachusetts. Clin Obes. 2021:e12453 Findings suggeting weight gain to be greater amongst women than men during the pandemic and in other subgroups.
Chew HSJ, Lopez V. Global impact of COVID-19 on weight and weight-related behaviors in the adult population: a scoping review. Int J Environ Res Public Health. 2021;18:1876.
Pell D, Mytton O, Penney TL, et al. Changes in soft drinks purchased by British households associated with the UK soft drinks industry levy: controlled interrupted time series analysis. BMJ. 2021;372:n254.
Childhood obesity: a plan for action, chapter 2 - GOV.UK. https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2. Accessed 4 May 2021
Valabhji J, Barron E, Bradley D, et al. Early outcomes from the English National Health Service Diabetes Prevention Programme. Diabetes Care. 2020;43:152–60.
New obesity strategy unveiled as country urged to lose weight to beat coronavirus (COVID-19) and protect the NHS - GOV.UK. https://www.gov.uk/government/news/new-obesity-strategy-unveiled-as-country-urged-to-lose-weight-to-beat-coronavirus-covid-19-and-protect-the-nhs. Accessed 4 May 2021
New specialised support to help those living with obesity to lose weight - GOV.UK. https://www.gov.uk/government/news/new-specialised-support-to-help-those-living-with-obesity-to-lose-weight. Accessed 4 May 2021
Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet. 2011;378:1485–92 (London, England).
Barron E, Clark R, Hewings R, Smith J, Valabhji J. Progress of the Healthier You: NHS Diabetes Prevention Programme: referrals, uptake and participant characteristics. Diabet Med. 2018;35:513–8.
Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541–51 (London, England).
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.
Frias JP, Nauck MA, Van J, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018;392:2180–93.
A study of tirzepatide (LY3298176) compared with dulaglutide on major cardiovascular events in participants with type 2 diabetes. https://clinicaltrials.gov/ct2/show/NCT04255433. Accessed 26 Mar 2021
Semaglutide effects on heart disease and stroke in patients with overweight or obesity - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03574597. Accessed 26 Mar 2021
Liakopoulos V, Franzén S, Svensson AM, Sattar N, Miftaraj M, Björck S, et al. Renal and cardiovascular outcomes after weight loss from gastric bypass surgery in type 2 diabetes: cardiorenal risk reductions exceed atherosclerotic benefits. Diabetes Care. 2020;43:1276–84.
Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson P-A, Taube M, et al. Life expectancy after bariatric surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020;383:1535–43.
NHS England. The Long Term Plan 2019. https://www.longtermplan.nhs.uk/wp-content/uploads/2019/01/nhs-long-term-plan-june-2019.pdf. Accessed 4 May 2021
Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26:320–5 A review paper which proposes newer ways to tackle obesity to get at many more at risk and to widen and simplify the spread of evidence based medicine in this area.
Kliemann N, Croker H, Johnson F, Beeken RJ. Development of the top tips habit-based weight loss app and preliminary indications of its usage, effectiveness, and acceptability: mixed-methods pilot study. JMIR mHealth uHealth. 2019;7:e12326.
Albury C, Strain WD, Le Brocq S, Logue J, Lloyd C, Tahrani A. The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement. Lancet Diabetes Endocrinol. 2020;8:447–55.
Lose weight - Better Health - NHS. https://www.nhs.uk/better-health/lose-weight/. Accessed 4 May 2021
How your GP can help you lose weight - NHS. https://www.nhs.uk/live-well/healthy-weight/how-your-gp-can-help-you-lose-weight/. Accessed 4 May 2021
Sattar N, Forouhi NG. More evidence for 5-a-day for fruit and vegetables and a greater need for translating dietary research evidence to practice. Circulation. 2021;143:1655–8.